Clemens J, Rao M, Sack D, Ahmed F, Khan M R, Chakraborty J, Kay B, Huda S, Yunus M, van Loon F
International Centre for Diarrheoal Disease Research, Bangladesh, Dhaka.
Am J Epidemiol. 1995 Oct 1;142(7):759-64. doi: 10.1093/oxfordjournals.aje.a117707.
In a field trial carried out in 1985 in Matlab, Bangladesh, the authors evaluated whether subjects who developed Vibrio cholerae 01 infections during the first year after earlier receipt of B subunit-killed whole cell (BS-WC) or killed whole cell-only (WC) oral cholera vaccines exhibited deficient serum vibriocidal immune responses to these infections. After severe V. cholerae 01 infections (n = 70) in subjects > 5 years of age, the age group in which both vaccines were efficacious, a 6.5 geometric mean-fold rise of serum vibriocidal antibodies was observed among vaccinees, compared with an 18.6 geometric mean-fold rise in placebo-recipients (p < 0.01). Depressions of serum vibriocidal responses among vaccinees were even more marked after asymptomatic infections (n = 30): a 1.1 geometric mean-fold rise in vaccinees versus a 5.9 geometric mean-fold rise in placebo-recipients (p < 0.01). The authors conclude that subjects who failed to be protected by BS-WC and WC, despite being in the age group for which these vaccines were protective, exhibited poor immune responses even to the vigorous stimulus of natural infection. These findings raise the possibility that immune hyporesponsiveness may limit the potential efficacy attainable by cholera vaccines in populations with endemic cholera.
1985年在孟加拉国马特莱开展了一项现场试验,作者评估了那些在较早前接种B亚单位-全菌体(BS-WC)或仅全菌体(WC)口服霍乱疫苗后第一年发生霍乱弧菌01感染的受试者,对这些感染的血清杀菌免疫反应是否不足。在5岁以上的受试者(两种疫苗在该年龄组均有效)发生严重霍乱弧菌01感染(n = 70)后,观察到疫苗接种者血清杀菌抗体几何平均升高6.5倍,而安慰剂接受者为18.6倍(p < 0.01)。在无症状感染(n = 30)后,疫苗接种者血清杀菌反应的降低更为明显:疫苗接种者几何平均升高1.1倍,而安慰剂接受者为5.9倍(p < 0.01)。作者得出结论,尽管处于疫苗有保护作用的年龄组,但未受到BS-WC和WC保护的受试者,即便面对自然感染的强烈刺激,免疫反应仍较差。这些发现增加了免疫低反应性可能会限制霍乱疫苗在霍乱流行人群中所能达到的潜在效力的可能性。